Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012)
Bausch Health Companies (BHC) reported Amortizatization of Intangibles of $3.2 million for Q1 2012, up 22.98% on a YoY basis from $2.6 million in Q2 2011, and up 63.51% sequentially from $2.0 million in Q4 2011.
Bausch Health Companies (BHC) Amortizatization of Intangibles (2009 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 4 years of Amortizatization of Intangibles data on file, last reported at $3.2 million in Q1 2012.
- For the quarter ending Q1 2012, Amortizatization of Intangibles rose 22.98% year-over-year to $3.2 million; the trailing twelve-month figure through Mar 2012 stood at $9.1 million (down 17.37% YoY), and the FY2011 full-year result was $8.5 million, down 23.98% from the prior year.
- Amortizatization of Intangibles rose to $3.2 million in Q1 2012, from $2.0 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q1 2012 to a low of $564000.0 in Q2 2009.
- A 4-year average of $2.4 million and a median of $2.7 million in 2009 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 403.01% in 2010 and plunged 31.44% in 2011, its largest moves.
- Tracing BHC's Amortizatization of Intangibles over 4 years: stood at $2.7 million in 2009, then grew by 2.88% to $2.8 million in 2010, then retreated by 29.51% to $2.0 million in 2011, then jumped by 63.51% to $3.2 million in 2012.
- Business Quant data shows BHC's Amortizatization of Intangibles at $3.2 million in Q1 2012, $2.0 million in Q4 2011, and $1.9 million in Q3 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.68 Bn | 367.46 Mn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 3.25 Mn |
| Mar 31, 2012 | 3.25 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Dec 31, 2011 | 1.99 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Sep 30, 2011 | 1.92 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Jun 30, 2011 | 1.95 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Mar 31, 2011 | 2.64 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Dec 31, 2010 | 2.82 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Sep 30, 2010 | 2.71 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Jun 30, 2010 | 2.84 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Mar 31, 2010 | 2.80 Mn |
| Dec 31, 2009 | 2.74 Mn |
| Dec 31, 2009 | 2.74 Mn |